Arundathy N. Pandite - Jan 25, 2023 Form 4 Insider Report for Shattuck Labs, Inc. (STTK)

Role
Chief Medical Officer
Signature
/s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite
Stock symbol
STTK
Transactions as of
Jan 25, 2023
Transactions value $
$0
Form type
4
Date filed
1/27/2023, 05:07 PM
Previous filing
Jan 12, 2023
Next filing
Jan 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STTK Common Stock Award $0 +37.9K +27.46% $0.00 176K Jan 25, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STTK Stock Option (Right to Buy) Award $0 +69.8K $0.00 69.8K Jan 25, 2023 Common Stock 69.8K $3.57 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer.
F2 This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.